Published in
Springer, Cancer Immunology, Immunotherapy, 2(72), p. 427-435, 2022
DOI: 10.1007/s00262-022-03265-7
Links
Tools
Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumab
Journal article published in 2022 by
Tatsuki Ikoma 
,
Mototsugu Shimokawa,
Toshihiko Matsumoto,
Shogen Boku,
Tomoyo Yasuda,
Nobuhiro Shibata,
Yusuke Kurioka,
Masahiro Takatani,
Tetsuji Nobuhisa,
Tsutomu Namikawa,
Hiroyuki Kitagawa,
Kazuhiro Hanazaki,
Keitaro Doi,
Takanobu Shimada,
Takehiko Tsumura
and other authors.
,
Mototsugu Shimokawa,
Toshihiko Matsumoto,
Shogen Boku,
Tomoyo Yasuda,
Nobuhiro Shibata,
Yusuke Kurioka,
Masahiro Takatani,
Tetsuji Nobuhisa,
Tsutomu Namikawa,
Hiroyuki Kitagawa,
Kazuhiro Hanazaki,
Keitaro Doi,
Takanobu Shimada,
Takehiko Tsumura
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 